Showing results (441-450 of 3,194) with videos related to
Sort By:
Pageof 320
American Journal of Clinical Pathology|October 1, 1982
Interlaboratory performance of disk agar diffusion and dilution antimicrobial susceptibility tests, 1979-1981. A summary of the microbiology portion of the College of American Pathologists (CAP) surveysR N Jones, D C EdsonThe Journal of Antimicrobial Chemotherapy|April 1, 1989
In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agentsA L Barry, R N JonesClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 27, 2003
Review of common therapeutic options in the United States for the treatment of pediculosis capitisKimberly N Jones, Joseph C EnglishDiagnostic Microbiology and Infectious Disease|July 18, 2003
Antagonism between penicillin and erythromycin against Streptococcus pneumoniae: does it exist?Lalitagauri M Deshpande, Ronald N JonesDiagnostic Microbiology and Infectious Disease|May 6, 2003
Comparative activity of garenoxacin (BMS 284756), a novel desfluoroquinolone, tested against 8,331 isolates from community-acquired respiratory tract infections: North American results from the SENTRY Antimicrobial Surveillance Program (1999-2001)Ronald N Jones, Douglas J BiedenbachDiagnostic Microbiology and Infectious Disease|May 14, 2003
Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance programDouglas J Biedenbach, Ronald N JonesDiagnostic Microbiology and Infectious Disease|June 1, 1983
Norfloxacin (MK-0366, AM-715): in vitro activity and cross-resistance with other organic acids including quality control limits for disk diffusion testingR N Jones, A L BarryReviews of Infectious Diseases|March 1, 1983
Cefoperazone: a review of its antimicrobial spectrum, beta-lactamase stability, enzyme inhibition, and other in vitro characteristicsR N Jones, A L BarryThe Medical Clinics of North America|July 1, 1994
Depression coexisting with dementia. Evaluation and treatmentB N Jones, B V ReiflerDiagnostic Microbiology and Infectious Disease|September 5, 2006
Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC program report from the United States component (2005)Paul R Rhomberg, Ronald N JonesPageof 320